Inducible activation of Ras and Raf in adult epidermis

Cancer Research

Volumn 63, Issue 2, 2003, Pages 319-323

  Tarutani, Masahito ^a   Cai, Ti ^a   Dajee, Maya ^a   Khavari, Paul A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; BETA1 INTEGRIN; BETA2 INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; EPIDERMIS CELL; FUSION GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HYPERPLASIA; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; RAF GENE; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECOMBINANT FUSION PROTEINS; SKIN; TAMOXIFEN;

EID: 0037439686     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Crespo, P., and Leon, J. Ras proteins in the control of the cell cycle and cell differentiation. Cell. Mol. Life Sci., 57: 1613-1636, 2000.
2. Marshall, C. J. Small GTPases and cell cycle regulation. Biochem. Soc. Trans., 27: 363-370, 1999.
3. Pierceall, W. E., Goldberg, L. H., Tainsky, M. A., Mukhopadhyay, T., and Ananthaswamy, H. N. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol. Carcinog., 4: 196-202, 1991.
4. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res., 54: 1178-1189, 1994.
5. Mainiero, F., Murgia, C., Wary, K. K., Curatola, A. M., Pepe, A., Blumemberg, M., Westwick, J. K., Der, C. J., and Giancotti, F. G. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J., 16: 2365-2375, 1997.
6. Zhu, A. J., Haase, I., and Watt, F. M. Signaling via β1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc. Natl. Acad. Sci. USA, 96: 6728-6733, 1999.
7. Dajee, M., Tarutani, M., Deng, H., Cai, T., and Khavari, P. A. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene, 21: 1527-1538, 2002.
8. Lin, A. W., and Lowe, S. W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA, 98: 5025-5030, 2001.
9. Roper, E., Weinberg, W., Watt, F. M., and Land, H. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep., 2: 145-150, 2001.
10. Brown, K., Strathdee, D., Bryson, S., Lambie, W., and Balmain, A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol., 8: 516-524, 1998.
11. Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., and Balmain, A. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62: 697-708, 1990.
12. Greenhalgh, D. A., Rothnagel, J. A., Quintanilla, M. I., Orengo, C. C., Gagne, T. A., Bundman, D. S., Longley, M. A., and Roop, D. R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog., 7: 99-110, 1993.
13. Ewen, M. E. Relationship between Ras pathways and cell cycle control. Prog. Cell Cycle Res., 4: 1-17, 2000.
14. Shields, J. M., Pruitt, K., McFall, A., Shaub, A., and Der, C. J. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol., 10: 147-154, 2000.
15. Genot, E., Reif, K., Beach, S., Kramer, I., and Cantrell, D. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB. Oncogene, 17: 1731-1738, 1998.
16. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol., 17: 5598-5611, 1997.
17. de Rooij, J., and Bos, J. L. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene. 14: 23-25, 1997.
18. Wolthuis, R. M., Zwartkruis, F., Moen, T. C., and Bos, J. L. Ras-dependent activation of the small GTPase Ral. Curr. Biol., 8: 471-474, 1998.
19. Li, A., Simmons, P. J., and Kaur, P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc. Natl. Acad. Sci. USA, 95: 3902-3907, 1998.
20. Savoia, P., Trusolino, L., Pepino. E., and Marchisio, P. C. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinomas display loss of α6,β4 and BM-600/nicein. J. Investig. Dermatol., 101: 352-358, 1993.
21. Berking, C., Takemoto, R., Binder, R. L., Hartman, S. M., Ruiter, D. J., Gallagher, P. M., Lessin, S. R., and Herlyn, M. Photocarcinogenesis in human adult skin grafts. Carcinogenesis, 23: 181-187, 2002.
22. Yuspa, S. H., Dlugosz, A. A., Denning, M. F., and Glick, A. B. Multistage carcinogenesis in the skin. J. Investig Dermatol. Symp Proc., 1: 147-150, 1996.
23. Watanabe, S., Ichikawa, E., Takahashi, H., and Otsuka, F. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy. Br. J. Dermatol. 132: 730-739, 1995.
24. von Lintig, F. C., Dreilinger, A. D., Varki, N. M., Wallace, A. M., Casteel, D. E., and Boss, G. R. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62: 51-62, 2000.
25. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
26. Mishima, K., Yamada, E., Masui, K., Shimokawara, T., Takayama, K., Sugimura, M., and Ichijima, K. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod. Pathol. 11: 886-891, 1998.